Cancer-Brochure-13-A5.Qxd:Layout 1
Total Page:16
File Type:pdf, Size:1020Kb
JOURNALS & BOOKS IN CANCER RESEARCH 2013 www.iospress.com IOS PRESS JOURNAL PROGRAM All IOS Press journals are published online and in print Visit www.iospress.com to: • Enter your subscription online • Check all subscription options including backfiles • Purchase articles on a pay-per-view basis • Obtain a free electronic sample copy • Scan tables of contents • Set up a journal alert • Find complete Instructions for Authors Open Library® : Open Access at IOS Press In addition to publishing work in traditional subscription journals, IOS Press offers the option to publish research with open access, i.e. free to use, download, circulate and disseminate by everyone, wherever in the world, as long as proper attribution is given to the author and the original source. The Open Library® option is available to all authors and for all journals published by IOS Press. IOS PRESS EBOOKS PROGRAM www.booksonline.iospress.com • Place your order online for ebooks or hardcopy books • Browse tables of contents • Read abstracts and preliminary pages free of charge • Search by subject or book series • Buy single titles and gain immediate access • Become a member and gain full access to all titles Follow us on Twitter: @IOSPress_STM JOURNALS Analytical Cellular Pathology www.iospress.com/journal/analytical-cellular-pathology Impact Factor: 0.917* ISSN 2210-7177 (print) / ISSN 2210-7185 (online) Analytical Cellular Pathology focuses on the burgeoning applications of physical techniques to the study of cells, tissues and organs in disease to elucidate pathogenesis and further translational research, enhanced diagnosis or prognostication, as well as new and better therapies. Of particular relevance are studies that explore the ways that aberrant biochemical and molecular pathways are transduced into the physical processes that underlie pathogenesis. The journal appeals to an audience of pathologists, cell biologists and biochemists, as well as biomedical engineers by focusing on new applications of the rapidly evolving array of technologies. Papers should be based on novel concepts, novel methodologies or the novel use of existing methodologies that contribute to the study of pathologic processes, rather than methodological details only. Approaches include tools such as biomedical photonics, surface resonance phenomena and impedance tomography, as well as new approaches for ultra-high resolution magnetic resonance, multispectral, hyperspectral and vibrational mode analysis and computational biology models. Hypothesis generating and hypothesis- testing observational studies are also welcome. Brief History Editor-in-Chief Analytical Cellular Stanley Cohen, MD, University of Medicine & Dentistry of New Jersey, Pathology was New Jersey Medical School, Newark, NJ, USA launched in 1988, Email: [email protected] changed its name to Cellular Oncology Coordinating Editor between 2005 and Marion C. Cohen, PhD, SUNY Downstate Medical Center, Brooklyn, NY, USA 2009 and then in Email: [email protected] 2010, reverted to Analytical Cellular Associate Editors Pathology: Cellular Ulysses J. Balis, USA Richard Levenson, USA Oncology. Since 2011 Elaine Bearer, USA Jonathan Reichner, USA it has continued as Hilary Coller, USA Thomas Ried, USA Analytical Cellular Walter Giaretti, Italy Gordon W. Stamp, United Kingdom Pathology. Ronald H. Goldfarb, USA Ronald S. Weinstein, USA Abstracting & Indexing Coverage Academic Source Complete, Biochemistry & Biophysics Citation Index, Biological Abstracts, BIOSIS Previews, CAB Abstracts, Chemical Abstracts Service (CAS), Current Contents/Clinical Medicine, Current Contents®/ Life Sciences, EBSCO Databases, Elsevier BIOBASE, Embase, Global Health, Journal Citation Reports/Science Edition, MEDLINE, Prous Science Integrity, PubMed, Science Citation Index Expanded (SciSearch®), Science Citation Index® (*Wos), Scopus, SIIC Data Bases Instructions for Authors www.iospress.com/journal/analytical-cellular-pathology/?tab=submission-of- manuscripts Subscription Information 2013 Volume 36 (6 issues) Institutional subscription (online only): US$995 / €715 Institutional subscription (print only): US$1079 / €775 *Journal Impact Factors from (including postage and handling) Journal Citation Reports® Science Edition 2011, published Institutional subscription (print and online): US$1278 / €918 by Thomson Reuters ©2012 (including postage and handling) Individual subscription (online only): US$250 / €210 Breast Disease An International Journal www.iospress.com/journal/breast-disease ISSN 0888-6008 (print) / ISSN 1558-1551 (online) The recent expansion of work in the field of breast cancer inevitably will hasten discoveries that will impact patient outcome. This research, that spans basic science, clinical medicine, epidemiology and public policy, poses difficulties for investigators. Not only is it necessary to be facile in comprehending ideas from many disciplines, but also, it is important to understand the public implications of these discoveries. Breast Disease publishes review issues devoted to in-depth analyses of the scientific and public implications of recent research on a specific problem in breast cancer. Meeting the information needs of scientists, clinicians and policy makers, the reviews not only discuss recent discoveries, but also reflect on their impact in breast cancer research or clinical management. Breast Disease now also publishes unsolicited peer-reviewed articles. Topics can cover basic cellular and molecular biology, epidemiology, genetics, clinical research, imaging and social and legal issues. Editor-in-Chief Jeffrey E. Green, MD, Bethesda, MD, USA Email: [email protected] Founding Editor Edison T. Liu, MD, Executive Director, Genome Institute of Singapore Abstracting & Indexing Coverage Academic Source Complete, Cancer Prevention and Control Database, Chemical Abstracts Service (CAS), EBSCO Databases, Elsevier BIOBASE, Embase, Epilepsy Education and Prevention Database, Health Education and Promotion Database, Index Medicus, MEDLINE, Prenatal Smoking Cessation Database, PubMed, Scopus Instructions for Authors www.iospress.com/journal/breast-disease/?tab=submission-of- manuscripts Subscription Information 2013 Volume 34 (4 issues) Institutional subscription (online only): US$590 / €420 Institutional subscription (print only): US$646 / €460 (including postage and handling) Institutional subscription (print and online): US$764 / €544 (including postage and handling) Individual subscription (online only): US$175 / €150 Cancer Biomarkers www.iospress.com/journal/cancer-biomarkers Impact Factor: 1.078* ISSN 1574-0153 (print) / ISSN 1875-8592 (online) Concentrating on molecular biomarkers in cancer research, Cancer Biomarkers publishes original research findings (and reviews solicited by the Editor-in-Chief) on the identification of markers associated with the disease processes, whether or not they are an integral part of the pathological lesion. The disease markers may include, but are not limited to, genomic, epigenomic, proteomics, cellular and morphologic and genetic factors predisposing to the disease or indicating the occurrence of the disease. Manuscripts on these factors or biomarkers, either in altered forms, abnormal concentrations or with abnormal tissue distribution leading to disease causation, are accepted. Editor-in-Chief Sudhir Srivastava, PhD, MPH, National Cancer Institute, NIH, Bethesda, MD, USA Email: [email protected] Associate Editors William E. Grizzle, MD, PhD Special Issues 2013 Anna Lokshin, PhD Beta-blockers in Attila T. Lorincz, PhD Cancer Paola Muti, MD Guest Editor: Karin D. Rodland, PhD Dr. Amal Melhem- Tesshi Yamada, MD, PhD Bertrand Abstracting & Indexing Coverage Biomarker Academic Source Complete, Biological Abstracts, BIOSIS Previews, Discordance in CAB Abstracts, Chemical Abstracts Service (CAS), Elsevier Breast Cancer BIOBASE, Embase, EMBIO, Journal Citation Reports/Science Guest Editors: Edition, MEDLINE, Prous Science Integrity, PubsHub, Science Naoto T. Ueno and Citation Index Expanded (SciSearch®), Scopus Naoki Niikura MiRNAs in Cancer: Instructions for Authors Non-coding RNAs www.iospress.com/journal/cancer-biomarkers/?tab=submission- as Appealing of-manuscripts Biomarkers for Malignancy Subscription Information 2013 Guest Editor: Volumes 13-14; 12 issues Pier Jr. Morin Institutional subscription (online only): US$1485 / €1090 Institutional subscription (print only): US$1653 / €1210 Cancer Biomarkers (including postage and handling) in Romenia: Institutional subscription (print and online): US$1950 / €1428 Realities and (including postage and handling) Perspectives Individual subscription (online only): US$300 / €250 Guest Editors: Ioana Berindan Neagoe and Angelo Paradiso *Journal Impact Factors from Journal Citation Reports® Science Edition 2011, published by Thomson Reuters ©2012 Disease Markers www.iospress.com/journal/disease-markers Impact Factor: 1.642* ISSN 0278-0240 (print) / ISSN 1875-8630 (online) Disease Markers publishes original research findings (and reviews solicited by the Editor-in-Chief) on the identification of markers associated with the disease processes, whether or not they are an integral part of the pathological lesion. The disease markers may be a genetic host factor predisposing to the disease or the occurrence of cell-surface markers, enzymes or other components, either in altered forms, abnormal concentrations or with abnormal tissue distribution. This journal is designed to provide a forum for publications dealing with original